IN-VITRO EFFECTS OF PROSTAGLANDIN-E1 AND INDOMETHACIN ON MITOMYCIN C-INDUCED SISTER-CHROMATID EXCHANGES IN MITOGEN-STIMULATED HUMAN-LYMPHOCYTES

Ekmekcı A., Saylı A., Donmez H., Bal F.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, vol.328, pp.49-53, 1995 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 328
  • Publication Date: 1995
  • Doi Number: 10.1016/0027-5107(94)00196-c
  • Journal Name: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chimica, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.49-53
  • Keywords: MITOMYCIN C, PROSTAGLANDIN E1, INDOMETHACIN, SISTER-CHROMATID EXCHANGE, HUMAN LYMPHOCYTES
  • Erciyes University Affiliated: Yes

Abstract

In this study, the individual and combined effects of prostaglandin E1 (PGE1) and Indomethacin on mitomycin C (MMC)-induced SCEs in human lymphocytes was investigated in vitro. All MMC-treated cultures showed a great increase of SCEs (approximately two-fold), indicating its ability to induce mutations. SCE data showed that MMC-induced SCEs were reduced significantly in the presence of PGE1 in pooled analysis of six experiments (60.55% reduction of SCEs at 10(-6) M, 34.13% reduction of SCEs at 10(-9) M). In contrast the presence of indomethacin in the medium during MMC treatment of cells failed to show a significant reduction of SCEs in pooled analysis (21.17%). However, individual analyses revealed only two of six donors with a significant SCE response. Thus, the findings suggest that PGE1 can modify the DNA damaging effect of carcinogens and thereby may prevent the initiation of the carcinogenic process.